A Comparative Study Evaluating the Vein of MArshall Ethanol Infusion Ablation Using an Over-the-wire (OTW) Balloon Versus a microcatHeter in Patients With Atrial Fibrillation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorShanghai Chest Hospital

About this trial

The goal of this study is to compare OTW balloon with microcatheter in the Marshall vein alcohol ablation study. The main questions it aims to answer are: • Is there a difference in the effectiveness and safety of OTW balloon and microcatheter in Marshall vein alcohol ablation? Participants will be asked to:

Undergo treatment with OTW balloon Undergo treatment with microcatheter If there is a comparison group: Researchers will compare the OTW balloon group and the microcatheter group to see different effects.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age range: 18-80 years.

Persistent atrial fibrillation or atrial flutter dependent on the mitral isthmus.

Inadequate response to antiarrhythmic drug therapy, or intolerance to antiarrhythmic drugs.

New York Heart Association functional class ≤ IV,with left ventricular ejection fraction (LVEF) ≥ 35%

Disqualifiers

Patients with known allergies to alcohol.

Participants with a history of serious cardiovascular events such as myocardial infarction or stroke within the past three months will be excluded from the study

Trial design

Design model

Parallel

Treatments tested in this trial

  • Microcatheter

    Device

    The microcatheter group undergoes alcohol ablation using a microcatheter.

  • OTW

    Device

    The OTW group undergoes alcohol ablation using an OTW balloon.

Treatment groups

800 Participants
are divided into 2 treatment groups
Group A: OTW groupPlacebo comparator 1 intervention
Group B: Microcatheter groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Acute rate of mitral isthmus block

Efficacy endpoints

Time frame
During catheter ablation procedures
2

Procedural complications

Safety endpoints

Time frame
During catheter ablation procedures
3

Recovery rate of the mitral isthmus line

Long-term primary efficacy endpoints

Time frame
beyond 3 months after the ablation procedure.

Secondary outcomes

1

Procedural characteristics

Time frame
Periprocedural period
2

Hospitalization costs

Time frame
Periprocedural period

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: